quinoline has been researched along with Neglected Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bland, ND; Campbell, RK; Ochiana, SO; Pollastri, MP; Settimo, L | 1 |
1 other study(ies) available for quinoline and Neglected Diseases
Article | Year |
---|---|
Repurposing human PDE4 inhibitors for neglected tropical diseases. Evaluation of analogs of the human PDE4 inhibitor GSK-256066 as inhibitors of PDEB1 of Trypanosoma brucei.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aminoquinolines; Binding Sites; Cyclic Nucleotide Phosphodiesterases, Type 4; Drug Repositioning; Humans; Molecular Docking Simulation; Neglected Diseases; Phosphodiesterase 4 Inhibitors; Protein Structure, Tertiary; Protozoan Proteins; Quinolines; Structure-Activity Relationship; Sulfones; Trypanosoma brucei brucei; Trypanosomiasis, African | 2015 |